FOXP3 and chronic obstructive pulmonary disease: Although STAT5 was increased in the COPD III and IV group, there was a decrease in Foxp3 expression and IL-10 levels in the COPD I and II and COPD III and IV groups, respectively, which was different from the tissue findings (27).